Tempus AI Inc.
Tempus AI Announces Acquisition of Personalis to Integrate MRD Technology
Summary
Tempus AI, Inc. has announced its agreement to acquire Personalis, Inc. for $1.5 billion, aiming to integrate Personalis's molecular residual disease (MRD) technology into its AI-enabled precision oncology platform. The acquisition, expected to close in late 2026 or early 2027, will expand Tempus's capabilities in MRD and enhance its ability to support patients from diagnosis to recurrence monitoring. Personalis shareholders will receive $16.25 per share, representing a 6% premium to Friday's closing price and a 28% premium to the unaffected 30-day volume-weighted average price (VWAP).
Profitelligence Alerts
Get alerts for TEM
Be first to know when Tempus AI Inc. files with the SEC.
Filing Categories
Advertisement
About Tempus AI Inc.
Tempus AI Inc. is a pioneering technology company specializing in the development and application of artificial intelligence solutions across various industries. Its primary function is to harness AI-driven insights to enhance operational efficiency and decision-making processes for enterprises. Tempus AI Inc. is at the forefront of integrating machine learning into sectors such as healthcare, finance, and logistics, where predictive data analytics can provide substantial competitive advantages. The company delivers bespoke AI platforms that enable organizations to streamline complex data sets into actionable intelligence. Its expertise extends to natural language processing and computer vision, offering comprehensive AI tools that drive innovation and efficiency. As a significant player in the tech market, Tempus AI Inc. contributes to setting industry standards for AI deployment, impacting how businesses leverage intelligent technology to improve outcomes and strategic planning. Founded with a mission to propel the development of intelligent systems, Tempus AI Inc. remains a vital contributor to the digital transformation of multiple industries, facilitating the transition towards a more data-driven future.
Official SEC Documents
Advertisement